Production (Stage)
T. Rowe Price Health Sciences Fund
PRHSX
NASDAQ
| Weiss Ratings | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | T. Rowe Price | |||
| Manager/Tenure (Years) | Ziad Bakri (9), Jason(Jay) Nogueira (0) | |||
| Website | http://www.troweprice.com | |||
| Fund Information | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | T. Rowe Price Health Sciences Fund | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 29, 1995 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.01% | |||
| Dividend | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.79% | |||
| Asset Allocation | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.79% | |||
| Stock | 90.23% | |||
| U.S. Stock | 78.69% | |||
| Non-U.S. Stock | 11.54% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.15% | |||
| Other Net | 8.83% | |||
| Price History | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.68% | |||
| 30-Day Total Return | -4.10% | |||
| 60-Day Total Return | -10.38% | |||
| 90-Day Total Return | -11.45% | |||
| Year to Date Total Return | -7.54% | |||
| 1-Year Total Return | -10.55% | |||
| 2-Year Total Return | -2.42% | |||
| 3-Year Total Return | 4.16% | |||
| 5-Year Total Return | 20.79% | |||
| Price | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $73.53 | |||
| 1-Month Low NAV | $72.70 | |||
| 1-Month High NAV | $79.43 | |||
| 52-Week Low NAV | $71.94 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $102.48 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.64 | |||
| Standard Deviation | 13.65 | |||
| Balance Sheet | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 12.07B | |||
| Operating Ratios | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.80% | |||
| Turnover Ratio | 52.40% | |||
| Performance | PRHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.44% | |||
| Last Bear Market Total Return | -9.89% | |||